baber/WOPTO huggingface dataset:
Patent EP-3062453-A2 (EP)
Inventor: MUTH EDWIN
IPC: H04B10/278
Filed: 2016-02-24
Abstract: An optical communication system is provided having a hierarchical branch configuration. The system includes first and second cable landing stations (CLS1, CLS2) coupled to a trunk path (102) in an optical cable (103). At least one hub-node (Node 1, Node 21... Node 51, Node 56, Node 60, Node 64) is coupled to the trunk path through an associated hub-node branching unit (BU1, BU21...BU51, BU56, BU60, BU64). Sub-nodes (Nodes 27-29, Nodes 31-33, Nodes 35-37, Nodes 57-58, Nodes 61-63) are coupled to the hub-nodes through associated sub-node branching units (BUs 27-29, BUs 31-33, BUs 35-37, BUs 57-58, BUs 61-63) and sub-node paths (112, 114, 132, 212, 214, 212a, 214a) in the optical cable. Sub-node signals may be communicated between the sub-nodes and the hub-nodes without being provided on the trunk path.
Patent EP-3298143-A2 (EP)
Title: Composition de poudre sèche comprenant de l'arn à chaîne longu
Inventor: YAZDAN PANAH BENYAMIN
IPC: A61K48/00
Filed: 2016-05-20
Abstract: La présente invention concerne une formulation d'ARN à chaîne longue stable au stockage. En particulier, l'invention concerne une composition de poudre sèche comprenant une molécule d'ARN à chaîne longue. La présente invention concerne en outre des procédés de préparation d'une composition de poudre sèche comprenant une molécule d'ARN à chaîne longue par séchage par atomisation ou pulvérisation-cryodessiccation. L'invention concerne en outre l'utilisation de ladite composition de poudre sèche comprenant une molécule d'ARN à chaîne longue dans la préparation de compositions pharmaceutiques et de vaccins, un procédé de traitement ou de prévention d'un trouble ou d'une maladie, une première et une seconde utilisations médicales de ladite composition de poudre sèche comprenant une molécule d'ARN à chaîne longue et des kits, en particulier des kits de parties, comprenant ladite composition de poudre sèche comprenant une molécule d'ARN à chaîne longue.
Patent EP-3329622-A2 (EP)
Inventor: RICO ALVARINO ALBERTO
IPC: H04L1/08
Filed: 2016-07-25
Abstract: La présente invention concerne des procédés, des systèmes et des dispositifs pour des communications sans fil. Un équipement d'utilisateur (UE), qui peut être un dispositif de communication de type machine et peut avoir une capacité semi-duplex, peut recevoir des octrois de ressources de liaison montante et de ressources de liaison descendante qui se chevauchent dans le temps. L'UE peut hiérarchiser les octrois et, soit abandonner l'octroi de faible priorité, soit surveiller une partie non en chevauchement de ressources attribuées par l'octroi de priorité inférieure, par exemple. Dans certains exemples, l'UE peut déterminer un mode d'accusé de réception pour la transmission de liaison descendante, sur la base d'un ou plusieurs octrois ou d'une indication explicite provenant d'une station de base. Un indicateur de format de commande peut être interprété d'après l'octroi ou la taille du groupage. Dans certains cas, l'UE peut identifier un temps de resyntonisation (par exemple, pour commuter entre des modes d'émission et de réception ou commuter des fréquences), et peut déterminer des tailles de groupage de liaison montante et de liaison descendante sur la base du temps de resyntonisation.
Patent EP-3318250-A2 (EP)
Inventor: ENGASHEV SERGEY VLADIMIROVICH
IPC: A61K31/4045
Filed: 2016-06-30
Abstract: The invention relates to the veterinary field in particular to a method for temporarily blocking sexual functions in female mammals, including behavioural phenomena (search for a partner, vocalization, etc.). The method for controlling sexual behaviour and contraception in female animals comprises administration of melatonin, gestagen and α-adrenergic blocking agent tropic to the posterior nuclei of the hypothalamus, while the combination of specified biologically active substances (BAS) is administered in therapeutic doses once during any period of the estrous cycle. A pharmaceutical composition for controlling sexual behaviour of female animals intended for the "Spot-on" transdermal administration, having pH in the range of 4.0 to 6.0 and containing therapeutic quantities of melatonin, gestagen and α-adrenergic blocking agent tropic to the posterior nuclei of the hypothalamus with the following ratio of the components (mass%): gestagen - therapeutic quantities; melatonin - therapeutic quantities; α-adrenergic blocking agent tropic to the posterior nuclei of the hypothalamus - therapeutic quantities; N-methyl-N-(1,2 R ,3 R ,4 R ,5 S -pentahydroxyhexyl)-octadecanamide - 0.5;  D -panthenol - 0.5; polyoxyethylated α-tocopherol - 10; polyoxyethylated lanolin - 1; 3-(octadecyloxy)-1,2-propanediol - 0.1; carboxylic acid - 0.1-1.1; N,N-diethyltoluamid - 15; 1,2-isopropylidene glycerol - 20; 1,2,3-triacetoxypropane - up to 100. The invention makes it possible, while using the minimal dose of the steroid hormone harmful to health of animals, to inhibit sexual behaviour of female animals for the period of 2 months to half a year (depending on the length of the daytime period). The pharmaceutical composition is intended for transdermal administration. The pharmaceutical composition also can be used in humane medicine for effective and safe contraception in the form of metered dose transdermal sprays for convenient application.
Patent EP-3327474-A2 (EP)
Inventor: CIPULLO ALESSIO
IPC: G02B6/293
Filed: 2017-11-28
Abstract: Various embodiments provide a communication apparatus for a fibre-optic communication system for a vehicle such as an aircraft. The apparatus comprises: an optical coupler; an input port optically coupled to the optical coupler via a first waveguide, the input port being arranged to receive light; a modulator optically coupled to the optical coupler via a second waveguide, the modulator comprising a logic input and a fibre having a fibre Bragg grating (FBG) arranged to receive the light from the input port via the optical coupler, the modulator being operable to vary a strain force applied to the fibre according to a logic signal received at the logic input to modulate a wavelength of a modulated light signal reflected by the FBG back to the optical coupler; and an output port optically coupled to the optical coupler via a third waveguide so as to receive the modulated light signal therefrom, the output port being operable to output the modulated light signal.
Patent EP-3363439-A2 (EP)
Inventor: FERNYHOUGH PAUL
IPC: A61P25/02
Filed: 2011-10-24
Abstract: Compositions for therapy of a diabetic symmetrical polyneuropathy a subject in need thereof, the compositions comprising: an effective amount of a muscarinic acetylcholine receptor antagonist exemplified by pirenzepine, telenzepine, atropine, or derivatives thereof or salts thereof or analogs thereof or derivatives thereof, and a pharmacologically acceptable carrier. The composition may be injectable or alternatively, may be applied topically or alternatively, may be delivered orally. A suitable topical composition may comprise a lotion, a cream, a gel, or a viscous fluid. The muscarinic acetylcholine receptor antagonist may be a muscarinic acetylcholine receptor antagonist salt or a muscarinic acetylcholine receptor antagonist derivative or a muscarinic acetylcholine receptor antagonist analog.
Patent EP-3444265-A2 (EP)
Inventor: CHO DAE HO
IPC: A61Q19/02
Filed: 2017-03-21
Abstract: The present invention relates to a peptide for skin regeneration or wound healing and a use thereof. The novel peptide according to the present invention not only promotes the wound healing by increasing the production amount of collagen in dermal fibroblasts but also has an excellent whitening effect by inhibiting the production amount of melanin and tyrosinase activity of melanoma cells, and consists of peptides having a very small size to minimize side effects according to administration of external substances of very small peptides. As a result, it is expected that the novel peptide can be used as an active substance that can replace existing skin regeneration or would therapeutic agents.
Patent EP-3535015-A2 (EP)
Inventor: LINDSAY RICHARD
IPC: A61M25/00
Filed: 2017-11-02
Abstract: The present disclosure relates to a drainage catheter and methods of use for providing improved catheterization procedures, such as during a percutaneous nephrostomy. The drainage catheter includes a body comprising a first tube segment and a second tube segment connected to one another at a curved end portion to form a continuous body structure. An inner surface of the curved end portion includes one or more drainage openings extending therethrough, with an outer surface of the curved end portion free of drainage openings to minimize potential clogging. The openings are in communication with a lumen that extends through the drainage catheter to provide a pathway for removing fluid from the kidney. The drainage catheter is inserted into the kidney via a first insertion site and exits via a second insertion site to minimize the potential for accidental removal of the catheter.
Patent EP-3496522-A2 (EP)
Inventor: LUNSMAN HARVEY J
IPC: H05K7/20
Filed: 2018-11-01
Abstract: Example implementations relate to a chassis cooling device. In some examples, a chassis cooling device may include a manifold (102-1..102-N) within the chassis to distribute a cooling resource among a cooling loop (104-1...104-N) and a heat exchanger (106); a first plurality of pumps (108-1,108-2), coupled to a cooling loop return portion of the manifold, arranged in parallel in the chassis to pump the cooling resource; and a second plurality of pumps (108-3,108-4), coupled to a cooling loop supply portion of the manifold, arranged in parallel in the chassis to pump the cooling resource, wherein the second plurality of pumps are arranged in series with the first plurality of pumps.
Patent EP-3492456-A2 (EP)
Inventor: SHIBUYA HIROMASA
IPC: C09K11/00
Filed: 2018-11-26
Abstract: Disclosed are a fullerene derivative including a substituent represented by Chemical Formula 1, and a photoelectric device, an image sensor, and an electronic device including the fullerene derivative.
     
In Chemical Formula 1, X, Ar, and R 1  to R 3  are the same as defined in the detailed description.
Patent EP-3573842-A2 (EP)
Inventor: HARNOIS MAXIME
IPC: B44C1/175
Filed: 2018-01-26
Abstract: Solvent transfer printing method for applying a pattern (1) made of a non-soluble material and non-dispersible (10) on the surface of an object (2), the method comprising the following steps: m1/ forming a pattern (1) on a surface of a solvent-soluble substrate (3), m2/ depositing the solvent-soluble substrate (3) on the surface of a solvent bath (5), on the side of the substrate opposed to the side on which the pattern is applied, in order to dissolve partially the substrate (3), m3/ dipping the object (2) in the bath (5), so that the surface of the object (2) comes into contact with the pattern (1), m4/ getting the object (2), on which the pattern (1) is applied, out of the bath (5), m5/ drying the object (2).
Patent EP-3592460-A2 (EP)
Inventor: JANKE CHRISTIANE
IPC: B01J23/89
Filed: 2018-03-09
Abstract: A catalyst for converting a synthesis gas, said catalyst comprising a first catalyst component and a second catalyst component, wherein the first catalyst component comprises, supported on a first porous oxidic substrate, Rh, Mn, an alkali metal M and Fe, and wherein the second catalyst component comprises, supported on a second porous oxidic support material, Cu and a transition metal other than Cu.
Patent EP-3604415-A2 (EP)
Inventor: GRADOV ALEKSEI SERGEEVICH
IPC: B29B17/00
Filed: 2018-05-17
Abstract: Die Erfindung betrifft die Technologie der Verwertung von Industrie- und Haushaltsabfällen. Anhand der Erfindung kann folgendes erreicht werden:Der Energieaufwand wird reduziert. Hohe schädliche Emissionen an die Umgebung werden vermindert. Die Qualität der Produkte der Abfallverwertung wird erhöht.Verfahren zur Verwertung von gummihaltigen Abfällen umfasst:- die Vorbehandlung der Abfälle,- die thermische Zersetzung der Abfälle im Ofen,- die Trennung der Abbauprodukte in Gas-Dampf-Gemisch und festen Rückstand,- die Absonderung (Abscheidung) der schweren Kohlenwasserstofffraktion aus dem Gas-Dampf-Gemisch.Bei der Vorbehandlung werden die Abfälle mit Wasserdampf (ein)geblasen. Thermische Zersetzung wird in der versprühten schweren Kohlenwasserstofffraktion und im überhitzen Wasserdampf bei deren Massenverhältnis (0,1 - 0,5) : 1 geführt. Die Absonderung (Abscheidung) der schweren Kohlenwasserstofffraktion aus dem Gas-Dampf-Gemisch erfolgt mit Wasser. Das Wasser wird im Gemischstrom in einer Menge von 5 bis 15 % vom Massenstrom (Massendurchsatz) des Gemisches gesprüht. Aus dem festen Rückstand wird durch Magnettrennung Metall abgeschieden. Danach wird durch dielektrische Trennung (Separation) ein zinkoxidhaltiges Produkt abgeschieden.
Patent EP-3541062-A2 (EP)
Inventor: ICHIMURA GEN
IPC: G06F13/00
Filed: 2007-11-05
Abstract: A signal processing system is provided, which includes a first converter for converting first information in to second information, a superimposer for superimposing on the second information control information corresponding to any missing information lost from the first information due to its conversion by the first converter. Furthermore, the signal processing system includes a transmitter for transmitting the second information, a receiver for receiving the second information transmitted from the transmitter, and an extractor for extracting the control information from the second information. The signal processing system also includes a second converter for converting the second information in to third information based on the control information extracted by the extractor, and an output portion for outputting the third information.
Patent EP-3740231-A2 (EP)
Title: Circuits de protéines programmables dans des cellules vivantes
Inventor: GAO XIAOJING
IPC: C07H21/04
Filed: 2019-01-17
Abstract: Certains modes de réalisation de la présente invention concernent des systèmes, des procédés et des compositions se rapportant à un composé protéase. Dans certains modes de réalisation, le composé protéase comprend un domaine de protéase et un site de coupure pour une autre enzyme. Dans certains modes de réalisation, le composé protéase comprend un domaine d'association. Dans certains modes de réalisation, le composé protéase est une partie d'un circuit de protéines.
Patent EP-3777330-A2 (EP)
Title: Detecting device movement and/or device usage within a vehicle
Inventor: SCHMITT KYLE PATRICK
IPC: H04M1/725
Filed: 2019-03-26
Abstract: Systems and methods are disclosed for receiving and transmitting accelerometer data and/or usage data, and analyzing the data to detect movement or usage of the device within a vehicle. A device, such as a mobile device, may detect a device movement event or a device usage event associated with the device. Based on the detection of the device movement event or the device usage event, a time associated with the event may be stored. The device may determine whether another event associated with the device occurs within a threshold amount of time from the time associated with the event. Based on a determination of whether the other event occurs within the threshold amount of time, the device may determine an event session associated with the device. The event session may comprise an instantaneous event or a continuous event. Data indicative of the event session may be transmitted to a server.
Patent EP-3840931-A2 (EP)
Title: Seilroboter-3d-drucker und verfahren zur lageerfassung und zur lageänderung des druckkopfes eines seilroboter-3d-druckers
Inventor: NIEDERBERGER ANTON
IPC: B33Y30/00
Filed: 2019-08-23
Abstract: Aufgabe der Erfindung ist es, einen 3D-Drucker zu schaffen, um beispielsweise Knochenersatz oder Organersatz oder andere Gegenstände wie Prothesen aus biokompatiblen Stoffen Seilroboter-3D-Drucker (1) umfassend einen Seilroboter (1) mit acht Seilen (2) oder Bändern (2) wobei die Seile (2) oder Bänder (2) an einem ersten Ende (3) an einem Druckkopf (4) lösbar befestigt sind und von dem Druckkopf (4) zu jeweils einer Seiltrommel (5) geführt sind und das andere vom Druckkopf (4) jeweils gegenüberliegende zweite Ende (6) der Seile (2) oder Bänder (2) in der Seiltrommel (5) planar kreuzungsfrei wickelbar sind, wobei die Seiltrommeln (5) innerhalb eines Arbeitsraumes (7) angeordnet sind und wobei die Seiltrommeln (5) antreibbar sind und die Antriebe (8) der Seiltrommeln (5) außerhalb oder innerhalb des Arbeitsraumes (7) angeordnet sind und dass an dem Druckkopf (4) zumindest eine Materialzufuhr (9) und zumindest eine Düse (10) vorgesehen ist. Verfahren zur Lageerfassung und zur Lageänderung des Druckkopfes (4) eines Seilroboter-3D-Drucker (1) umfassend einen Seilroboter (1) mit acht Seilen (2) oder Bändern (2) die von einem Druckkopf (4) zu jeweils einer Seiltrommel (5) geführt sind, dadurch gekennzeichnet, dass die Seile (2) oder Bänder (2) in der Seiltrommel (5) planar kreuzungsfrei gewickelt werden und für einen Regelkreis zur Erfassung der Sollposition als Messgrößen die jeweiligen Seillängen, welche über Encoder an den Antrieben (8) erfasst und als Stellgrößen des Regelkreises die Seilkräfte ermittelt werden.
Patent EP-3946351-A2 (EP)
Inventor: CHOUNG JAI JUN
IPC: A61K31/522
Filed: 2020-03-24
Abstract: The present invention provides methods for reducing amyloid beta formation and for treating diseases associated with the accumulation of amyloid beta., The present invention provides (1) A β aggregation inhibition by A β Oligomer / Fibril formation inhibition, (2) BACE-1 reduced a through β- Amyloidogenic Processing inhibition, (3) cerebral blood flow to the increase of the cell outer Αβ Monomer, Oligomer & Αβ Fibril / Plaque reduction, (4) NO / cGMP / PKG / CREB Pathway to the activation of Neuronal cell Death inhibition and Neurogenesis, Synaptogenesis, Angiogenesis promotion, (5) DKK-1 inhibition by Wnt Signaling in the activation of synaptic plasticity recovery and Αβ production Positive Feedback Loop for inhibition of APP generates reduced and Αβ accumulation suppression, (6) Autophagy activation by cells within Toxic Mirodenafil, Sildenafil, Vardenafil, Tadalafil, Udenafil, Dasantafil, and Avanafil for the treatment of inhibition of Αβ Fibril / Plaque formation through removal of Soluble Αβ Oligomer; and a Pharmaceutically Acceptable Salt, Solvate, and Hydrate in selected compounds key of ingredient containing drug compound composition, and this with the treatment method provided.
Patent EP-3999078-A2 (EP)
Inventor: BHOWMICK TUHIN
IPC: A61K38/19
Filed: 2020-07-18
Abstract: The present disclosure provides a process for obtaining an expanded primed mesenchymal stem cell population. In the process, the MSCs are cultured in the culture medium comprising a corneal stromal stem cell derived-conditioned medium to obtain the expanded population of the primed mesenchymal stem cell population along with the mesenchymal stem cell derived-conditioned medium. Also, provided is a method of culturing the MSCs in 3D culture using a spheroid-based method or a microcarrier-based method, in order to obtain the expanded primed mesenchymal stem cell population. Further, an exosome preparation obtained from the expanded primed mesenchymal stem cell derived-conditioned medium is also disclosed herein. The present disclosure also discloses a composition comprising an expanded population of the primed mesenchymal stem cells, or a primed mesenchymal stem cell derived-conditioned medium, or an exosome preparation, or combinations thereof.
Patent EP-4005569-A2 (EP)
Title: Compositions for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto
Inventor: NATHAN ILANA
IPC: A61K31/00
Filed: 2016-04-07
Abstract: Inhibitor compounds and agents of Cathepsin C, CELA1, CELA3A and/or structurally related molecules thereto, compositions comprising same and uses thereof in the inhibition and/or prevention of cell and/or tissue necrosis is described. Various applications for the described compounds, and combination therapies are described as well.
Patent EP-4026751-A2 (EP)
Title: Foldable stroller, foldable bassinet, foldable seat, stroller and stroller and luggage system
Inventor: NIEUWENHUIZEN MARCO WILLEM HENDRIUS
IPC: B62B9/26
Filed: 2021-12-16
Abstract: The present application discloses a foldable stroller (1) with a wheeled foldable chassis (9), an interchangeable foldable bassinet (7) and foldable seat, a stroller and luggage system and an arrangement of stroller wheels (71, 81) with front wheels mounted via a swivel joint (75).
Patent EP-3991678-A2 (EP)
Title: Electrosurgical instruments and connections thereto
Inventor: BRUSTED JOHN R
IPC: A61B18/00
Filed: 2011-10-03
Abstract: An electrosurgical instrument includes jaws having an electrode configuration utilized to electrically modify tissue in contact with one or more electrodes. The instrument is removably connectable to an electrosurgical unit via an electrosurgical connector extending from the instrument and a receptacle on the electrosurgical unit. The electrosurgical instrument is rotatable without disrupting electrical connection to the electrodes of the jaws. One or more of the electrodes is retractable. The electrosurgical unit and instrument optimally seals and/or cuts tissue based on identifying the tissue and monitoring the modification of the tissue by the application of radio frequency energy.
Patent EP-4182008-A2 (EP)
Inventor: ARLOTTI MATTIA
IPC: A61B5/00
Filed: 2021-07-16
Abstract: In some variations provided herein, a system for deep brain stimulation includes an implantable device that acquire and store neural activity signal records and apply electrical stimulation. The system further includes a personal controller device that establishes a first wireless connection to the implantable device. The personal controller device transmits power to the implantable device, and the implantable device transmits neural activity signal records to the personal controller device over the first wireless connection. The system further includes a clinician programmer device that receive the neural activity signal records from the implantable device by establishing a second wireless connection based on activation of the first wireless connection. The clinician programmer device sets one or more stimulation parameters based on the neural activity signal records.
Patent EP-4214627-A2 (EP)
Inventor: BAUCHOT FRÉDÉRIC
IPC: G06K7/14
Filed: 2021-09-15
Abstract: Aspects of the present invention disclose a method, computer program product, and system for determining information based on a received image. The method includes one or more processors receiving image data from a computing device. The method further includes one or more processors identifying an object included in the received image data. The method further includes one or more processors determining a value that corresponds to the identified object included in the received image data. The method further includes one or more processors determining whether the determined value corresponds to a defined action. Another aspect of the present invention discloses an apparatus that includes a foreground label overlaying a background label, and a measurement device coupled to the foreground label. The measurement device is capable of movement in response to observing measurement data.
Patent EP-4066762-A2 (EP)
Inventor: KORMAN ZACHARY
IPC: A61B17/86
Filed: 2022-03-10
Abstract: Provided is a nested screw assembly and a related method for fusing a joint between two bones using the nested screw assembly, where the nested screw assembly includes a cannulated outer screw and an inner screw.